A novel association between filamin A and NF-κB inducing kinase couples CD28 to inhibitor of NF-κB kinase α and NF-κB activation

Immunology Letters

Volumn 136, Issue 2, 2011, Pages 203-212

  Muscolini, Michela ^a   Sajeva, Angela ^a   Caristi, Silvana ^a   Tuosto, Loretta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CD28; Filamin A; NF B; T cells

Indexed keywords

CD28 ANTIGEN; FILAMIN A; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NF KAPPA B INDUCING KINASE; PROLINE; T LYMPHOCYTE RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN MOTIF; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD28; ANTIGENS, CD80; CONTRACTILE PROTEINS; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; JURKAT CELLS; L CELLS (CELL LINE); MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROLINE-RICH PROTEIN DOMAINS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ALIGNMENT;

EID: 79953027260     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.01.011     Document Type: Article

References (61)

1. Acuto O., Mise-Omata S., Mangino G., Michel F. Molecular modifiers of T cell antigen receptor triggering threshold: the mechanism of CD28 costimulatory receptor. Immunol Rev 2003, 192:21-31.
2. Rudd C.E., Taylor A., Schneider H. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 2009, 229:12-26.
3. Kundig T.M., Shahinian A., Kawai K., Mittrucker H.W., Sebzda E., Bachmann M.F., et al. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 1996, 5:41-52.
4. Kane L.P., Lin Y., Weiss A. It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol 2002, 23:413-420.
5. Takeda K., Harada Y., Watanabe R., Inutake Y., Ogawa S., Onuki K., et al. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis. Int Immunol 2008, 20:1507-1515.
6. Harhaj E.W., Sun S.C. IkappaB kinases serve as a target of CD28 signaling. J Biol Chem 1998, 273:25185-25190.
7. Marinari B., Costanzo A., Marzano V., Piccolella E., Tuosto L. CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. Proc Natl Acad Sci USA 2004, 101:6098-6103.
8. Marinari B., Costanzo A., Viola A., Michel F., Mangino G., Acuto O., et al. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1. Eur J Immunol 2002, 32:447-456.
9. Mattioli I., Sebald A., Bucher C., Charles R.P., Nakano H., Doi T., et al. Transient and selective NF-kappa B p65 serine 536 phosphorylation induced by T cell costimulation is mediated by I kappa B kinase beta and controls the kinetics of p65 nuclear import. J Immunol 2004, 172:6336-6344.
10. Verma I.M., Stevenson J.K., Scharz E.M., Van Antwerp D.V., Miyamoto S. Rel/NF-kB/IkB family: intimate tails of association and dissociation. Genes Dev 1995, 9:2723-2735.
11. DiDonato J.A., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IkB kinase that activates the transcription factor NF-kB. Nature 1997, 388:548-554.
12. Reigner C.H., Song H.Y., Gao X., Goedell D.V., Cao Z., Rothe M. Identification and characterization of an IkB kinase. Cell 1997, 90:373-383.
13. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is essential regulatory subunit of the IkB kinase complex. Nature 1998, 395:297-300.
14. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IkB kinase b: NF-kB activation and complex formation with IkB kinase-a and NIK. Science 1997, 278:866-869.
15. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998, 93:1231-1240.
16. Zandi E., Rothwarf D.M., Delhase M., Hyakawa M., Karin M. The IκB kinase complex(IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997, 91:243-252.
17. Luo J.L., Kamata H., Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 2005, 115:2625-2632.
18. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., et al. Activation by IKKα of a second evolutionary conserved, NF-κB signaling pathway. Science 2001, 293:1495-1499.
19. Coope H.J., Atkinson P.G.P., Huhse B., Belich M., Janzen J., Holman M.J., et al. CD40 regulates the processing of NF-kB2 p100 to p52. EMBO J 2002, 21:5375-5385.
20. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 2002, 17:525-535.
21. Sun Z., Arendt C.W., Ellmeier W., Schaeffer E.M., Sunshine M.J., Gandhi L., et al. PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 2000, 404:402-407.
22. Villalba M., Bi K., Hu J., Altman Y., Bushway P., Reits E., et al. Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K- and Vav-dependent pathway, but does not absolutely require phospholipase C. J Cell Biol 2002, 157:253-263.
23. Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R., Rueda D., et al. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 2008, 9:272-281.
24. Tanner M.J., Hanel W., Gaffen S.L., Lin X. CARMA1 coiled-coil domain is involved in the oligomerization and subcellular localization of CARMA1 and is required for T cell receptor-induced NF-kappaB activation. J Biol Chem 2007, 282:17141-17147.
25. Wang D., Matsumoto R., You Y., Che T., Lin X.Y., Gaffen S.L., et al. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol 2004, 24:164-171.
26. Piccolella E., Spadaro F., Ramoni C., Marinari B., Costanzo A., Levrero M., et al. Vav-1 and the IKK alpha subunit of I kappa B kinase functionally associate to induce NF-kappa B activation in response to CD28 engagement. J Immunol 2003, 170:2895-2903.
27. Cianfrocca R., Muscolini M., Marzano V., Annibaldi A., Marinari B., Levrero M., et al. RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells. Cell Death Differ 2008, 15:354-363.
28. Cai Y.C., Cefai D., Schneider H., Raab M., Nabavi N., Rudd C.E. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 1995, 3:417-426.
29. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., et al. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat Immunol 2001, 2:325-332.
30. Holdford A.D., Green J.M., Levin S.D., Denny M.F., Straus D.B., Link P.S., et al. Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med 1999, 190:375-384.
31. Tavano R., Gri G., Molon B., Marinari B., Rudd C.E., Tuosto L., et al. CD28 and lipid rafts coordinate recruitment of Lck to the immunological synapse of human T lymphocytes. J Immunol 2004, 173:5392-5397.
32. Kim H.H., Tharayil M., Rudd C.E. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling. J Biol Chem 1998, 273:296-301.
33. Tavano R., Contento R.L., Baranda S.J., Soligo M., Tuosto L., Manes S., et al. CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse. Nat Cell Biol 2006, 8:1270-1276.
34. Xiao G., Harhaj E.W., Sun S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 2001, 7:401-409.
35. Kane L.P., Abdres P.G., Howland K.C., Abbas A.K., Weiss A. Akt provides the CD28 costimulatory signal for up-reulation of IL-2 and IFN-gamma but not TH2 cytokines. Nat Immunol 2001, 2:37-44.
36. Sanchez-Lockhart M., Graf B., Miller J. Signals and sequences that control CD28 localization to the central region of the immunological synapse. J Immunol 2008, 181:7639-7648.
37. Watanabe R., Harada Y., Takeda K., Takahashi J., Ohnuki K., Ogawa S., et al. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J Immunol 2006, 177:1085-1091.
38. Burr J.S., Savage N.D., Messah G.E., Kimzey S.L., Shaw A.S., Arch R.H., et al. Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J Immunol 2001, 166:5331-5335.
39. Parry R.V., Rumbley C.A., Vandenberghe L.H., June C.H., Riley J.L. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J Immunol 2003, 171:166-174.
40. Zhou A.X., Hartwig J.H., Akyurek L.M. Filamins in cell signaling, transcription and organ development. Trends Cell Biol 2010, 20:113-123.
41. Hayashi K., Altman A. Filamin A is required for T cell activation mediated by protein kinase C-theta. J Immunol 2006, 177:1721-1728.
42. Grech A.P., Amesbury M., Chan T., Gardam S., Basten A., Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 2004, 21:629-642.
43. Liao G., Zhang M., Harhaj E.W., Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem 2004, 279:26243-26250.
44. Claudio E., Brown K., Park S., Wang H., Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002, 3:958-965.
45. Dejardin E. The alternative NF-[kappa]B pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem Pharmacol 2006, 72:1161-1179.
46. Yokosuka T., Kobayashi W., Sakata-Sogawa K., Takamatsu M., Hashimoto-Tane A., Dustin M.L., et al. Spatiotemporal regulation of T cell costimulation by TCR-CD28 microclusters and protein kinase C theta translocation. Immunity 2008, 29:589-601.
47. Schwartz R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992, 71:1065-1068.
48. Tuosto L. NF-kappaB family of transcription factors: biochemical players of CD28 co-stimulation. Immunol Lett 2010.
49. Luhder F., Huang Y., Dennehy K.M., Guntermann C., Muller I., Winkler E., et al. topological requirements and signaling properties of T-cell activating, anti-CD28 antibody superagonists. J Exp Med 2003, 197:955-966.
50. Beyersdorf N., Hanke T., Kerkau T., Hunig T. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases. Ann Rheum Dis 2005, 64(Suppl. 4):iv91-iv95.
51. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006, 355:1018-1028.
52. Li Y., Sedwick C.E., Hu J., Altman A. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation. J Biol Chem 2005, 280:1217-1223.
53. Harhaj E.W., Maggirwar S.B., Good L., Sun S.C. CD28 mediates a potent costimulatory signal for rapid degradation of IkappaBbeta which is associated with accelerated activation of various NF-kappaB/Rel heterodimers. Mol Cell Biol 1996, 16:6736-6743.
54. Lai J.H., Tan T.H. CD28 signaling causes a sustained down-regulation of I kappa B alpha which can be prevented by the immunosuppressant rapamycin. J Biol Chem 1994, 269:30077-30080.
55. Sanchez-Lockhart M., Marin E., Graf B., Abe R., Harada Y., Sedwick C.E., et al. Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol 2004, 173:7120-7124.
56. Parry R.V., Whittaker G.C., Sims M., Edmead C.E., Welham M.J., Ward S.G. Ligation of CD28 stimulates the formation of a multimeric signaling complex involving grb-2-associated binder 2 (gab2), SRC homology phosphatase-2, and phosphatidylinositol 3-kinase: evidence that negative regulation of CD28 signaling requires the gab2 pleckstrin homology domain. J Immunol 2006, 176:594-602.
57. Harada Y., Ohgai D., Watanabe R., Okano K., Koiwai O., Tanabe K., et al. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J Exp Med 2003, 197:257-262.
58. Matsushima A., Kaisho T., Rennert P.D., Nakano H., Kurosawa K., Uchida D., et al. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J Exp Med 2001, 193:631-636.
59. Yin L., Wu L., Wesche H., Arthur C.D., White J.M., Goeddel D.V., et al. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 2001, 291:2162-2165.
60. Lin X., Cunningham E.T., Mu Y., Geleziunas R., Greene W.C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Immunity 1999, 10:271-280.
61. Sanchez-Valdepenas C., Punzon C., San-Antonio B., Martin A.G., Fresno M. Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells. Cell Signal 2007, 19:528-537.